Dr. Mark R. Harrigan grew up in Minnesota and received a B.S. degree in Economics from the University of Minnesota. He received an M.D. degree from the University of Washington in Seattle, Washington, in 1995. During medical school he was the recipient of the American Federation for Clinical Research E.E. Osgood Award, the Roche Laboratories Award in Basic Science, and the American Medical Association Award for Outstanding Clinical Research.
Dr. Harrigan then did his general surgery internship and neurological surgery residency at the University of Michigan Medical Center under the direction of Dr. Julian Hoff from 1995 to 2002. During his residency, he spent 18 months in the laboratory of Dr. Richard Keep studying cerebral blood flow and the effects of angiogenic factors on cerebral blood flow and ischemia. During this time he also participated in the introduction of clinical cerebral blood flow measurement techniques at the University of Michigan Medical Center, including xenon-CT and CT perfusion. He was the recipient of the Pharmacia Upjohn Research Fellowship in Cerebrovascular Disease, the Michigan Association of Neurological Surgeons Resident Award, and the Fifth International Conference on Xenon CT-CBF Young Investigator Award.
Upon completion of his residency, he did a fellowship in Neuroendovascular Surgery at SUNY Buffalo under the direction of Dr. Nick Hopkins from 2002 to 2004. During this time he received the Sean Mullen Neuroendovascular Fellowship.
Upon completion of his fellowship, Dr. Harrigan joined the faculty of the University of Birmingham at Birmingham as an Assistant Professor of Neurosurgery and Radiology. There, under the mentorship of Dr. Winfield Fisher, he did a fellowship in Cerebrovascular Neurosurgery.
Dr. Harrigan's clinical and research interests focus on cerebrovascular disorders. His clinical practice includes the operative and endovascular treatment of cerebrovascular disease, as well as general neurosurgery and neurosurgical critical care. He is the Principle Investigator for three ongoing UAB IRB-approved clinical trials involving new endovascular devices and is a co-investigator for the NIH-sponsored CREST Study, which is a randomized trial comparing surgery to angioplasty and stenting for patients with carotid artery disease. He is active in resident education and was a recipient of a Top Ten Award for Excellence in Resident Education from the Department of Radiology. He is also the coauthor, with Dr. John Deveikis, of the Handbook of Cerebrovascular Disease and Neurointerventional Technique, which is currently in press with Springer.
Dr. Harrigan's clinic is on Tuesdays and Wednesdays at the Kirklin Clinic. Appointments and referrals can be made by calling 205-996-2536.